Tissue- and cell-specific whole-transcriptome meta-analysis from brain and retina reveals differential expression of dystrophin complexes and new dystrophin spliced isoforms
Open Access
- 20 September 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 32 (4), 659-676
- https://doi.org/10.1093/hmg/ddac236
Abstract
The large DMD gene encodes a group of dystrophin proteins in brain and retina, produced from multiple promoters and alternative splicing events. Dystrophins are core components of different scaffolding complexes in distinct cell types. Their absence may thus alter several cellular pathways, which might explain the heterogeneous genotype–phenotype relationships underlying central comorbidities in Duchenne muscular dystrophy (DMD). However, the cell-specific expression of dystrophins and associated proteins (DAPs) is still largely unknown. The present study provides a first RNA-Seq-based reference showing tissue- and cell-specific differential expression of dystrophins, splice variants and DAPs in mouse brain and retina. We report that a cell type may express several dystrophin complexes, perhaps due to expression in separate cell subdomains and/or subpopulations, some of which with differential expression at different maturation stages. We also identified new splicing events in addition to the common exon-skipping events. These include a new exon within intron 51 (E51b) in frame with the flanking exons in retina, as well as inclusions of intronic sequences with stop codons leading to the presence of transcripts with elongated exons 40 and/or 41 (E40e, E41e) in both retina and brain. PCR validations revealed that the new exons may affect several dystrophins. Moreover, immunoblot experiments using a combination of specific antibodies and dystrophin-deficient mice unveiled that the transcripts with stop codons are translated into truncated proteins lacking their C-terminus, which we called N-Dp427 and N-Dp260. This study thus uncovers a range of new findings underlying the complex neurobiology of DMD.Funding Information
- Centre National de la Recherche Scientifique
- France-Mexico collaborative research (M16SO1/276330)
- Consejo Nacional de Ciencia y Tecnología, Guatemala (CB-2017-2018-A1-S-24868)
This publication has 70 references indexed in Scilit:
- Upregulation of brain utrophin does not rescue behavioral alterations in dystrophin-deficient miceHuman Molecular Genetics, 2012
- Dystrophins, Utrophins, and Associated Scaffolding Complexes: Role in Mammalian Brain and Implications for Therapeutic StrategiesJournal of Biomedicine and Biotechnology, 2010
- Role of Mental Retardation-Associated Dystrophin-Gene Product Dp71 in Excitatory Synapse Organization, Synaptic Plasticity and Behavioral FunctionsPLOS ONE, 2009
- Cognitive and Psychological Profile of Males With Becker Muscular DystrophyJournal of Child Neurology, 2007
- Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exonsJournal of Human Genetics, 2007
- Six Novel Transcripts That Remove a Huge Intron Ranging from 250 to 800 kb Are Produced by Alternative Splicing of the 5′ Region of the Dystrophin Gene in Human Skeletal MuscleBiochemical and Biophysical Research Communications, 1997
- Dp140: Alternatively Spliced Isoforms in Brain and KidneyGenomics, 1997
- Targeted Disruption of Exon 52 in the Mouse Dystrophin Gene Induced Muscle Degeneration Similar to That Observed in Duchenne Muscular DystrophyBiochemical and Biophysical Research Communications, 1997
- Improved Splice Site Detection in GenieJournal of Computational Biology, 1997
- ZZ and TAZ: new putative zinc fingers in dystrophin and other proteinsTrends in Biochemical Sciences, 1996